✦ LIBER ✦

Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) Trial in Symptomatic Intracranial Stenosis

✍ Scribed by Zaidat, Osama O.; Castonguay, Alicia C.; Fitzsimmons, Brian-Fred; Woodward, Britton Keith; Wang, Zhigang; Killer-Oberpfalzer, Monika; Wakhloo, Ajay; Gupta, Rishi; Kirshner, Howard; Eliasziw, Misha; Thomas Megerian, J.; Shetty, Sujith; Yoklavich Guilhermier, Meg; Barnwell, Stanley; Smith, Wade S.; Gress, Daryl R.

Book ID: 122967804
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 370 KB
Volume: 22
Category: Article
ISSN: 1532-8511
DOI: 10.1016/j.jstrokecerebrovasdis.2012.10.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design of the Stenting and Aggressive Me

Design of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial

✍ Marc I. Chimowitz; Michael J. Lynn; Tanya N. Turan; David Fiorella; Bethany F. L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Stent design lowers angiographic but not

Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis – results of a single center study with 100 consecutive patients

✍ S. Rohde; J. Seckinger; S. Hähnel; P. A. Ringleb; M. Bendszus; M. Hartmann 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Statin pretreatment may increase the ris

Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case–control study and a meta-analysis

✍ Sergi Martinez-Ramirez; Raquel Delgado-Mederos; Rebeca Marín; Marc Suárez-Calvet 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 346 KB

The Neuroprotection with Statin Therapy

The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke

✍ Mitchell S. V. Elkind; Ralph L. Sacco; Robert B. MacArthur; Daniel J. Fink; Elli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Rationale and design of the EMBRACE STEM

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

✍ Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra; Brown, David A.; Czyz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB